April 26, 2018
Via: FortuneThe outlook was grim for Novo Nordisk at the end of 2016. As pressure mounted over its rising insulin prices, investors drove the stock down by a third, fearing that lawmakers would cap price tags and hurt profits. So last […]
July 9, 2024
July 18, 2024
July 12, 2024